In prostate cancer, the role of MVD as an independent prognostic factor is unclear: In a large study, manually counted MVD was correlated to tumor aggressiveness and was a predictor of prostate-specific antigen (PSA) recurrence after initial prostatectomy, but was not an independent prognostic factor [13]. The gene discussed is KLK3; the disease is prostate carcinoma.